Stockreport

Insider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ... [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF The transaction was executed at an average price of $39.75 per share, resulting in a total value of $795,000. Halozyme Therapeutics Inc is a biopharmaceutical company [Read more]